StreetInsider.com News Articles

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida.

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Wed, 20 May 2026 07:00:00 -0400

Algernon Health changes name to Grey Matters Health, implements 10:1 share consolidation

Wed, 15 Apr 2026 16:01:30 -0400

Algernon Health Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) will change its corporate name to Grey Matters Health Inc. effective April 21, 2026, according to a company statement. The Canadian healthcare company will simultaneously implement a 10-to-1 share consolidation.

The company will begin trading under the new ticker symbol "GREY" on the Canadian Securities Exchange. The new CUSIP number will be 397884107 and the ISIN number will be CA3978841078 for the post-consolidation common shares. Trading under the new structure is expected to commence on or around April 21, 2026.

Following the consolidation, the total number of issued and outstanding common shares will

Algernon Health changes name to Grey Matters Health, implements 10:1 share consolidation

Wed, 15 Apr 2026 16:01:30 -0400

Following the consolidation, the total number of issued and outstanding common shares will

Algernon Health changes name to Grey Matters Health, implements 10:1 share consolidation

Wed, 15 Apr 2026 16:01:30 -0400

Following the consolidation, the total number of issued and outstanding common shares will

Algernon Health changes name to Grey Matters Health, implements 10:1 share consolidation

Wed, 15 Apr 2026 16:01:30 -0400

Following the consolidation, the total number of issued and outstanding common shares will

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Wed, 15 Apr 2026 16:01:00 -0400

VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that effective April 21, 2026 its corporate name will change from “Algernon Health Inc.” to “Grey Matters Health Inc.” and the Company will consolidate its Class A common shares (the “Common Shares”) on a ten (10) to one (1) basis (the “Consolidation”) as previously announced on March 31, 2026.

The Company will begin trading under the new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Wed, 15 Apr 2026 16:01:00 -0400

The Company will begin trading under the new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Wed, 15 Apr 2026 16:01:00 -0400

The Company will begin trading under the new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Wed, 15 Apr 2026 16:01:00 -0400

The Company will begin trading under the new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Wed, 15 Apr 2026 16:01:00 -0400

The Company will begin trading under the new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Wed, 15 Apr 2026 16:01:00 -0400

The Company will begin trading under the new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Wed, 15 Apr 2026 16:01:00 -0400

The Company will begin trading under the new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new

Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation

Wed, 15 Apr 2026 16:01:00 -0400

The Company will begin trading under the new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new

Algernon Health plans name change to Grey Matters Health, 10:1 share consolidation

Tue, 31 Mar 2026 19:10:13 -0400

Algernon Health Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) announced plans to change its corporate name to Grey Matters Health Inc. and implement a 10:1 share consolidation, according to a company statement.

The Vancouver-based healthcare company has reserved the new name and trading symbol "GREY" with the Canadian Securities Exchange. New symbols for the OTCQB and Frankfurt exchanges will be announced later.

The company stated the name change reflects its focus on the Alzheimer's disease diagnostic market and plans to establish brain PET scanning clinics across the United States under the NovaScan Neuroimaging Clinics brand. The first clinic will be located at

Algernon Health plans name change to Grey Matters Health, 10:1 share consolidation

Tue, 31 Mar 2026 19:10:13 -0400

Algernon Health plans name change to Grey Matters Health, 10:1 share consolidation

Tue, 31 Mar 2026 19:10:13 -0400